<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://onwar.se/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://onwar.se/feed.php">
        <title>Onwards - pt-141_vs_sildenafil</title>
        <description></description>
        <link>https://onwar.se/</link>
        <image rdf:resource="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg" />
       <dc:date>2026-09-26T05:06:12+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://onwar.se/doku.php?id=pt-141_vs_sildenafil:a_comparative_mechanism_of_action_study&amp;rev=1790346510&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg">
        <title>Onwards</title>
        <link>https://onwar.se/</link>
        <url>https://onwar.se/lib/exe/fetch.php?media=wiki:dokuwiki.svg</url>
    </image>
    <item rdf:about="https://onwar.se/doku.php?id=pt-141_vs_sildenafil:a_comparative_mechanism_of_action_study&amp;rev=1790346510&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-09-25T14:28:30+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>a_comparative_mechanism_of_action_study</title>
        <link>https://onwar.se/doku.php?id=pt-141_vs_sildenafil:a_comparative_mechanism_of_action_study&amp;rev=1790346510&amp;do=diff</link>
        <description>The world of sexual medicine and pharmacology has evolved dramatically over the past few decades. For millions of individuals journey sexual dysfunction, the quest for reliable, efficacious, and targeted therapeutic agents remains a major focus of clinical research and consumer interest. Historically, the advent of phosphodiesterase type 5 inhibitors transformed the management of erectile dysfunction, offering a peripheral vascular solution to a complex physiological and psychological challenge.…</description>
    </item>
</rdf:RDF>
